Total Payments
$4,589
2024 Payments
$1,871
Companies
26
Transactions
221
Medicare Patients
410
Medicare Billing
$64,355
Payment Breakdown by Category
Food & Beverage$4,444 (96.8%)
Education$144.99 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,444 | 219 | 96.8% |
| Education | $144.99 | 2 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,043 | 54 | $0 (2024) |
| Janssen Biotech, Inc. | $562.84 | 23 | $0 (2024) |
| ABBVIE INC. | $559.08 | 33 | $0 (2024) |
| UCB, Inc. | $429.54 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $294.52 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $286.47 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $225.31 | 14 | $0 (2024) |
| GENZYME CORPORATION | $178.20 | 7 | $0 (2024) |
| Penumbra, Inc. | $150.00 | 1 | $0 (2024) |
| PFIZER INC. | $135.58 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,871 | 86 | Amgen Inc. ($378.12) |
| 2023 | $1,619 | 78 | Amgen Inc. ($374.96) |
| 2022 | $1,079 | 56 | Amgen Inc. ($290.35) |
| 2021 | $18.55 | 1 | UCB, Inc. ($18.55) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $6.55 | General |
| Category: Immunology | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $23.25 | General |
| Category: Immunology | ||||||
| 10/17/2024 | SCILEX PHARMACEUTICALS INC. | GLOPERBA (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Analgesic | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Rheumatology | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Rare Disease | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: Dermatology | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 198 | 391 | $69,365 | $30,129 |
| 2022 | 3 | 156 | 262 | $54,220 | $25,668 |
| 2021 | 2 | 56 | 76 | $16,970 | $8,559 |
Total Patients
410
Total Services
729
Medicare Billing
$64,355
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 228 | $44,170 | $19,769 | 44.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $19,800 | $8,255 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 21 | $2,945 | $1,361 | 46.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 70 | $2,450 | $743.72 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 162 | $30,780 | $15,425 | 50.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 71 | 71 | $19,525 | $8,258 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 29 | $3,915 | $1,986 | 50.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 46 | $8,720 | $4,638 | 53.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $8,250 | $3,920 | 47.5% |
About Dr. Sarah Compton, MD
Dr. Sarah Compton, MD is a Rheumatology healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1871973487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Compton, MD has received a total of $4,589 in payments from pharmaceutical and medical device companies, with $1,871 received in 2024. These payments were reported across 221 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,444).
As a Medicare-enrolled provider, Compton has provided services to 410 Medicare beneficiaries, totaling 729 services with total Medicare billing of $64,355. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Hickory, NC
- Active Since 06/09/2015
- Last Updated 03/22/2022
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1871973487
Products in Payments
- Enbrel (Biological) $789.96
- TREMFYA (Drug) $412.03
- RINVOQ (Biological) $407.29
- Cimzia (Drug) $376.63
- ORENCIA (Biological) $286.47
- COSENTYX (Drug) $270.04
- SAPHNELO (Biological) $225.31
- KEVZARA (Biological) $178.20
- SKYRIZI (Biological) $151.79
- Indigo System (Device) $150.00
- XELJANZ (Drug) $135.58
- STRENSIQ (Biological) $116.93
- REMICADE (Biological) $103.18
- TAVNEOS (Drug) $94.30
- PURIFIED CORTROPHIN GEL (Drug) $91.39
- Tavneos (Drug) $70.00
- OPSUMIT (Drug) $56.60
- Bimzelx (Biological) $52.91
- AMJEVITA (Biological) $49.68
- GLOPERBA (Drug) $49.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.